| Full text | |
| Author(s): |
Silva, Adriana F.
;
Torres, Marcelo D. T.
;
Silva, Leandro S.
;
Alves, Flavio L.
;
Miranda, Antonio
;
Oliveira Jr, Vani X.
;
de la Fuente-Nunez, Cesar
;
Pinheiro, Ana Acacia S.
Total Authors: 8
|
| Document type: | Journal article |
| Source: | SCIENTIFIC REPORTS; v. 14, n. 1, p. 9-pg., 2024-02-26. |
| Abstract | |
Malaria can have severe long-term effects. Even after treatment with antimalarial drugs eliminates the parasite, survivors of cerebral malaria may suffer from irreversible brain damage, leading to cognitive deficits. Angiotensin II, a natural human peptide hormone that regulates blood pressure, has been shown to be active against Plasmodium spp., the etiologic agent of malaria. Here, we tested two Ang II derivatives that do not elicit vasoconstriction in mice: VIPF, a linear tetrapeptide, which constitutes part of the hydrophobic portion of Ang II; and Ang II-SS, a disulfide-bridged derivative. The antiplasmodial potential of both peptides was evaluated with two mouse models: an experimental cerebral malaria model and a mouse model of non-cerebral malaria. The latter consisted of BALB/c mice infected with Plasmodium berghei ANKA. The peptides had no effect on mean blood pressure and significantly reduced parasitemia in both mouse models. Both peptides reduced the SHIRPA score, an assay used to assess murine health and behavior. However, only the constrained derivative (Ang II-SS), which was also resistant to proteolytic degradation, significantly increased mouse survival. Here, we show that synthetic peptides derived from Ang II are capable of conferring protection against severe manifestations of malaria in mouse models while overcoming the vasoconstrictive side effects of the parent peptide. (AU) | |
| FAPESP's process: | 14/12938-6 - Biologically active peptides against pathogenic micro-organisms |
| Grantee: | Vani Xavier de Oliveira Junior |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 15/08527-3 - Antiplasmodial angiotensin II derivatives studies in vivo & in vitro |
| Grantee: | Adriana Farias da Silva |
| Support Opportunities: | Scholarships in Brazil - Post-Doctoral |